0000899243-23-015206.txt : 20230609 0000899243-23-015206.hdr.sgml : 20230609 20230609165626 ACCESSION NUMBER: 0000899243-23-015206 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230607 FILED AS OF DATE: 20230609 DATE AS OF CHANGE: 20230609 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Johnson David Michael CENTRAL INDEX KEY: 0001808098 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40971 FILM NUMBER: 231006099 MAIL ADDRESS: STREET 1: C/O ZENTALIS PHARMACEUTICALS, LLC STREET 2: 530 SEVENTH AVENUE, SUITE 2201 CITY: NEW YORK STATE: NY ZIP: 10018 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aura Biosciences, Inc. CENTRAL INDEX KEY: 0001501796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 320271970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 80 GUEST STREET CITY: BOSTON STATE: MA ZIP: 01235 BUSINESS PHONE: (617)500-8864 MAIL ADDRESS: STREET 1: 80 GUEST STREET CITY: BOSTON STATE: MA ZIP: 01235 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-07 0 0001501796 Aura Biosciences, Inc. AURA 0001808098 Johnson David Michael C/O AURA BIOSCIENCES, INC. 80 GUEST STREET BOSTON MA 01235 1 0 0 0 0 Stock Option (Right to Buy) 12.83 2023-06-07 4 A 0 16000 0.00 A 2033-06-07 Common Stock 16000 16000 D This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 7, 2024 or (b) the next annual meeting of the Issuer's stockholders. /s/ Julie Feder, Attorney-in-fact 2023-06-09